BRPI0914797A2 - derivados de éter de pirrolidina como antagonistas do receptor de nk3 - Google Patents
derivados de éter de pirrolidina como antagonistas do receptor de nk3Info
- Publication number
- BRPI0914797A2 BRPI0914797A2 BRPI0914797A BRPI0914797A BRPI0914797A2 BR PI0914797 A2 BRPI0914797 A2 BR PI0914797A2 BR PI0914797 A BRPI0914797 A BR PI0914797A BR PI0914797 A BRPI0914797 A BR PI0914797A BR PI0914797 A2 BRPI0914797 A2 BR PI0914797A2
- Authority
- BR
- Brazil
- Prior art keywords
- receptor antagonists
- ether derivatives
- pyrrolidine
- pyrrolidine ether
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08157952 | 2008-06-10 | ||
| PCT/EP2009/056989 WO2009150110A1 (en) | 2008-06-10 | 2009-06-08 | Pyrrolidine ether derivatives as nk3 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0914797A2 true BRPI0914797A2 (pt) | 2015-10-27 |
Family
ID=40823481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0914797A BRPI0914797A2 (pt) | 2008-06-10 | 2009-06-08 | derivados de éter de pirrolidina como antagonistas do receptor de nk3 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8063075B2 (pt) |
| EP (1) | EP2294063B1 (pt) |
| JP (1) | JP2011522855A (pt) |
| KR (1) | KR20110010768A (pt) |
| CN (1) | CN102056918A (pt) |
| AR (1) | AR072078A1 (pt) |
| AT (1) | ATE531709T1 (pt) |
| AU (1) | AU2009256680A1 (pt) |
| BR (1) | BRPI0914797A2 (pt) |
| CA (1) | CA2720285A1 (pt) |
| ES (1) | ES2376188T3 (pt) |
| IL (1) | IL207577A0 (pt) |
| MX (1) | MX2010011161A (pt) |
| TW (1) | TW200951123A (pt) |
| WO (1) | WO2009150110A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2738870A1 (en) * | 2008-10-09 | 2010-04-15 | F. Hoffmann-La Roche Ag | Pyrrolidine n-benzyl derivatives |
| MX2011007506A (es) * | 2009-01-30 | 2011-08-04 | Hoffmann La Roche | Derivados de piperidina como antagonistas del receptor de neuroquinina 3 (nk3). |
| US8318759B2 (en) * | 2009-02-18 | 2012-11-27 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives as NK3 receptor antagonists |
| US8324250B2 (en) * | 2009-03-19 | 2012-12-04 | Hoffmann-La Roche Inc. | Piperidine derivatives as NK3 receptor antagonists |
| US8394834B2 (en) | 2009-08-25 | 2013-03-12 | Hoffman-La Roche Inc. | Pyrrolidines as NK3 receptor antagonists |
| US20110152233A1 (en) | 2009-12-18 | 2011-06-23 | Henner Knust | Pyrrolidine compounds |
| US8507535B2 (en) * | 2010-07-07 | 2013-08-13 | Hoffmann-La Roche Inc. | Methyl-pyrrolidine ether derivatives |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6642226B2 (en) * | 2001-02-06 | 2003-11-04 | Hoffman-La Roche Inc. | Substituted phenyl-piperidine methanone compounds |
| JP4339890B2 (ja) | 2003-09-22 | 2009-10-07 | エフ．ホフマン−ラ ロシュ アーゲー | アミノアルキルアミド置換シクロヘキシル誘導体 |
| EP1670476A4 (en) * | 2003-09-30 | 2009-05-27 | Merck & Co Inc | ANTAGONISTS OF TACHYKININ RECEPTOR BASED ON PHENYL PYRROLIDINE ETHER |
| JP2007537233A (ja) * | 2004-05-12 | 2007-12-20 | ファイザー・プロダクツ・インク | Ｎｋ１及びｎｋ３アンタゴニストとしてのピペリジン誘導体 |
| US7138423B2 (en) | 2004-07-20 | 2006-11-21 | Bristol-Myers Squibb Company | Arylpyrrolidine derivatives as NK-1 /SSRI antagonists |
| GB0417852D0 (en) | 2004-08-11 | 2004-09-15 | Biotica Tech Ltd | Production of polyketides and other natural products |
| JP2006298909A (ja) | 2005-03-25 | 2006-11-02 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| JP2007084530A (ja) * | 2005-08-22 | 2007-04-05 | Sankyo Co Ltd | インダノール誘導体を含有する医薬組成物 |
| JP2007277231A (ja) * | 2006-03-16 | 2007-10-25 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| JP2010536818A (ja) * | 2007-08-22 | 2010-12-02 | エフ．ホフマン−ラ ロシュ アーゲー | Ｎｋ３受容体アンタゴニストとしてのピロリジンアリール−エーテル |
-
2009
- 2009-06-02 US US12/476,267 patent/US8063075B2/en not_active Expired - Fee Related
- 2009-06-08 WO PCT/EP2009/056989 patent/WO2009150110A1/en active Application Filing
- 2009-06-08 MX MX2010011161A patent/MX2010011161A/es active IP Right Grant
- 2009-06-08 AU AU2009256680A patent/AU2009256680A1/en not_active Abandoned
- 2009-06-08 CA CA2720285A patent/CA2720285A1/en not_active Abandoned
- 2009-06-08 BR BRPI0914797A patent/BRPI0914797A2/pt not_active IP Right Cessation
- 2009-06-08 CN CN2009801213286A patent/CN102056918A/zh active Pending
- 2009-06-08 KR KR1020107027683A patent/KR20110010768A/ko not_active Application Discontinuation
- 2009-06-08 AT AT09761673T patent/ATE531709T1/de active
- 2009-06-08 JP JP2011512944A patent/JP2011522855A/ja active Pending
- 2009-06-08 ES ES09761673T patent/ES2376188T3/es active Active
- 2009-06-08 EP EP09761673A patent/EP2294063B1/en not_active Not-in-force
- 2009-06-09 TW TW098119268A patent/TW200951123A/zh unknown
- 2009-06-09 AR ARP090102063A patent/AR072078A1/es unknown
-
2010
- 2010-08-12 IL IL207577A patent/IL207577A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009256680A1 (en) | 2009-12-17 |
| AR072078A1 (es) | 2010-08-04 |
| ES2376188T3 (es) | 2012-03-09 |
| CA2720285A1 (en) | 2009-12-17 |
| JP2011522855A (ja) | 2011-08-04 |
| CN102056918A (zh) | 2011-05-11 |
| EP2294063B1 (en) | 2011-11-02 |
| WO2009150110A1 (en) | 2009-12-17 |
| EP2294063A1 (en) | 2011-03-16 |
| KR20110010768A (ko) | 2011-02-07 |
| TW200951123A (en) | 2009-12-16 |
| US20090306043A1 (en) | 2009-12-10 |
| ATE531709T1 (de) | 2011-11-15 |
| US8063075B2 (en) | 2011-11-22 |
| MX2010011161A (es) | 2010-11-01 |
| IL207577A0 (en) | 2010-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0821141A2 (pt) | Derivados de heteroarila como antagonistas do receptor de orexina | |
| BRPI0909157A2 (pt) | compostos heterocíclicos como antagonistas de receptores de adenosina | |
| BRPI0913930A2 (pt) | antagonistas de receptores de prostaglandinas d2 | |
| BRPI0919844A2 (pt) | compostos de azaindazol como antagonistas do receptor ccr1 | |
| BRPI0810462A2 (pt) | Derivados de quinolina-carboxamida como antagonistas de p2y12 | |
| BRPI0717023A2 (pt) | Tiazol pirazolopirimidina como antagonistas do receptor de crf1 | |
| BRPI1013821A2 (pt) | piridinas substituídas como antagonistas de ccr3. | |
| BRPI0815674A2 (pt) | Aril-éter de pirrolidina como antagonista de receptor de nk3 | |
| BRPI0817245A2 (pt) | Derivados e quinolina como antagonistas receptores de 5ht5a | |
| BRPI0813768A2 (pt) | Derivados de benzazepina úteis como antagonistas de vasopressina | |
| BRPI1016189A2 (pt) | compostos de 4-azetidinil-1-fenil-ciclohexano antagonistas de ccr2 | |
| ATE517100T1 (de) | Pyrrolidinarylether als nk3-rezeptorantagonisten | |
| BRPI0717937A2 (pt) | Compostos de pirazona como antagonistas do receptor mineralocorticóide | |
| BRPI0814806A2 (pt) | Pirazinas substituídas como antagonistas de cb1 | |
| BRPI0814767A2 (pt) | Derivados de monoamida como antagonistas do receptor de orexina | |
| BRPI0817061A2 (pt) | Derivados de pirrolidinilalquilisoquinolinona e -isoindolinona como antagonistas de histamina-3 | |
| SMT201300020B (it) | Derivati di isochinolinone come antagonisti dei recettori nk3 | |
| BRPI0920247A2 (pt) | benzimidazóis heterocíclicos como moduladores de trpm8. | |
| BRPI1013617A2 (pt) | derivados de piperidina como antagonistas de receptor de nk3 | |
| BRPI0914797A2 (pt) | derivados de éter de pirrolidina como antagonistas do receptor de nk3 | |
| BRPI0915834A2 (pt) | 6-(1-piperazinil)-piridazinas substituídas como antagonistas do receptor de 5-ht6 | |
| BR112012003976A2 (pt) | antagonistas de receptor glyt1 carbocíclico | |
| BRPI0720078A2 (pt) | 2-aminoquinolinas como antagonistas de receptores de 5-ht(5a) | |
| BRPI0914779A2 (pt) | derivados de pirrolidina como antagonistas de receptor de nk2 | |
| BRPI0822693A2 (pt) | Derivados de quinuclidina como antagonistas do receptor muscarínico m3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |